SCOTUS rejects plea to review DABUS decision

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

SCOTUS rejects plea to review DABUS decision

ai robot thinking

The US Supreme Court will not hear a case that determines whether AI can be listed as an inventor on a patent application

The US Supreme Court declined to hear a petition for a writ of certiorari over whether artificial intelligence can be listed as an inventor on Monday, April 24.

Stephen Thaler filed the petition last month after the Court of Appeals for the Federal Circuit rejected his attempt to list an AI tool called DABUS as the inventor on a patent application.

The Federal Circuit’s decision, handed down in August last year, upheld both a summary judgment from the District Court for the Eastern District of Virginia and the USPTO’s initial rejection of the application.

Though Thaler was unsuccessful, The Chicago Patent Attorneys, Brooklyn Law Incubator & Policy Clinic, and a group of four professors filed amicus briefs in his favour.

The USPTO declined to respond to the petition unless asked by SCOTUS.

Thaler has sought to get DABUS named as an inventor around the world. Last month, the UK Supreme Court, which has agreed to hear the case, heard oral arguments in the dispute.

Each of the intellectual property offices where DABUS applications have been filed has rejected them except for South Africa’s, which does not conduct substantive pre-grant examination.

The campaign enjoyed little success in the courts until the Federal Court of Australia found in 2021 that Australia’s Patents Act did not explicitly require an inventor to be a natural person.

However, that finding was overturned in November last year.


more from across site and SHARED ros bottom lb

More from across our site

Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
A former Freshfields counsel and an ex-IBM counsel, who have joined forces at law firm Caldwell, say clients are increasingly sophisticated in their IP demands
Daniel Raymond, who will serve as head of client relations, tells Managing IP that law firms must offer ‘brave’ opinions if they want to keep winning new business
The new outfit, Ashurst Perkins Coie, will bring together around 3,000 lawyers across 23 countries
Gift this article